Scott Robert Henry Sells 3,000 Shares of NEXGEL, Inc. (NASDAQ:NXGL) Stock

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the stock in a transaction on Friday, December 20th. The shares were sold at an average price of $4.64, for a total value of $13,920.00. Following the sale, the director now owns 144,553 shares in the company, valued at approximately $670,725.92. This represents a 2.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

NEXGEL Trading Up 1.7 %

Shares of NASDAQ:NXGL opened at $4.74 on Wednesday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.51 and a quick ratio of 0.93. NEXGEL, Inc. has a 1 year low of $1.84 and a 1 year high of $5.10. The company has a market cap of $32.19 million, a P/E ratio of -8.17 and a beta of 0.76. The stock’s fifty day moving average price is $3.45 and its 200-day moving average price is $2.85.

Hedge Funds Weigh In On NEXGEL

An institutional investor recently raised its position in NEXGEL stock. Northeast Financial Group Inc. boosted its stake in shares of NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,848 shares of the company’s stock after purchasing an additional 20,000 shares during the period. Northeast Financial Group Inc. owned about 0.50% of NEXGEL worth $82,000 at the end of the most recent reporting period. Institutional investors own 2.21% of the company’s stock.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.